Vascular anomalies represent a spectrum of disorders from a simple “birthmark” to life-
threatening entities. Incorrect nomenclature and misdiagnoses are commonly experienced …

Infantile hemangioma (IH) is the most common pediatric vascular tumor. Its pathogenesis is
poorly understood but thought to represent an aberrant response of pluripotent stem cells to …

Background Oral propranolol has been used to treat complicated infantile hemangiomas,
although data from randomized, controlled trials to inform its use are limited. Methods We …

Infantile hemangiomas (IHs) are the most common tumors of childhood. Unlike other tumors,
they have the unique ability to involute after proliferation, often leading primary care …

Background The aetiology and exact incidence of infantile haemangiomas (IHs) are
unknown. Prior studies have noted immunohistochemical and biological characteristics …

METHODS: We searched Embase and Medline databases (2007–July 2014) and
unpublished data from the manufacturer of Hemangiol/Hemangeol (marketed pediatric …

OBJECTIVES: A subgroup of patients with infantile hemangiomas have associated structural
anomalies of the brain, cerebral vasculature, eyes, sternum, and/or aorta in the …

To systematically review the literature evaluating efficacy and adverse events of propranolol
treatment for infantile hemangiomas, we searched the MEDLINE and Cochrane databases …

Hemangioma of infancy is a condition that may be associated with significant morbidity.
While evidence most supports the use of corticosteroids, there is no well‐defined or Federal …

OBJECTIVE: To provide incidence data based on ethnicity, prematurity, and body site for
vascular, pigmented, and other common congenital cutaneous findings; to compare these …